{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:14:00Z","timestamp":1761765240305},"reference-count":50,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"vor","delay-in-days":31,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurourology and Urodynamics"],"published-print":{"date-parts":[[2010,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>To review if the existing data support the new concept that antimuscarinic agents can be used for the treatment of bladder outlet obstruction (BOO) with coexisting overactive bladder (OAB).<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>A literature search of Medline publications (up to 2008) on use of antimuscarinic agents for treatment BOO was performed and all data were presented. All relevant data from published studies in congress abstracts were as well included.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The existing data show that this treatment effectively improves patient quality of life. Concerns about the possibility of urinary retention were shown to be unfounded. It seems that antimuscarinic agents do not affect voiding pressures and the use of antimuscarinic agents for BOO seems safe.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The combination of an \u03b1\u2010blocker and antimuscarinic agent for the treatment of BOO with concomitant OAB seems promising. Neurourol. Urodynam. 29:S46\u2013S50, 2010. \u00a9 2010 Wiley\u2010Liss, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/nau.20807","type":"journal-article","created":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T20:13:22Z","timestamp":1265055202000},"source":"Crossref","is-referenced-by-count":10,"title":["Antimuscarinics and bladder outlet obstruction: From a contraindication to an indication?"],"prefix":"10.1002","volume":"29","author":[{"given":"Anastasios","family":"Athanasopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,4,13]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2003.08.015"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90543-X"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)65075-4"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2006.02.018"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67776-2"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0302-2838(02)00540-7","article-title":"Antimuscarinics and the overactive detrusor\u2014Which is the main mechanism of action?","volume":"43","author":"Anderson KE","year":"2003","journal-title":"Eur Urol"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2003.09.030"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/nau.20487"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1523\/JNEUROSCI.10-06-01943.1990","article-title":"Morfological plasticityin efferent pathways to the urinary bladder of the rat following urethral obstruction","volume":"10","author":"Steers WD","year":"1990","journal-title":"J Neurosci"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(97)00038-7"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)62083-4"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2007.12.007"},{"key":"e_1_2_1_14_2","first-page":"525","article-title":"A comparative study of the efficacy and safety of tamsulosin hydrochloride alone and combination of propiverine hydrochloride and tamsulosin hydrochloride in the benign prostatic hypertrophy with pollakisuria and\/or urinary incontinence","volume":"8","author":"Saito H","year":"1999","journal-title":"Jpn J Urol Surg"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000067541.73285.eb"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2004.05039.x"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000173630.94559.fd"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.19.2319"},{"key":"e_1_2_1_19_2","first-page":"1590","article-title":"Clinical effectiveness and safety study of combined therapy with an alpha\u2010blocker and an anticholinerrgic for patients with LUT\/BPH","volume":"87","author":"Xia H","year":"2007","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.6.14.2429"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042307-200401000-00003"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2004.05022.x"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000176460.62847.23"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2006.07.017"},{"key":"e_1_2_1_25_2","first-page":"85","article-title":"The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta\u2010analysis","volume":"99","author":"Blake\u2010James T","year":"2006","journal-title":"BIU Int"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.7.4.473"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(03)00588-0"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2006.06258.x"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2007.02.057"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2008.04.038"},{"key":"e_1_2_1_31_2","first-page":"857","article-title":"Efficacy of treatment with propiverine hydrochloride in patients on lower urinary tract function\u2010BUP\u20104 tablets special study group II","volume":"12","author":"Nishimatsou H","year":"1999","journal-title":"Jpn J Urol Surg"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)00483-0"},{"key":"e_1_2_1_33_2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0022-5347(18)38166-7","article-title":"Use of muscarinic receptor antagonists as monotherapy in men with lower urinary tract symptoms who failed previous therapy with alpha blockers","volume":"171","author":"Kaplan SA","year":"2004","journal-title":"J Urol"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000181823.33224.a0"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.5.1.151"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-9056(02)00118-5"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(82)90127-3"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1159\/000049889"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1994.tb07477.x"},{"key":"e_1_2_1_40_2","first-page":"308","article-title":"Combination treatment with an a\u2010blocker plus an anticholinergic improves quality of life in patients with bladder outlet obstruction. A prospective, randomized controlled study","volume":"21","author":"Athanasopoulos A","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2005.5547_3.x"},{"key":"e_1_2_1_42_2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0022-5347(18)38583-5","article-title":"Propiverine hydrochloride relieves irritative symptoms of benign prostatic hyperplasia","volume":"171","author":"Okada H","year":"2004","journal-title":"J Urol"},{"key":"e_1_2_1_43_2","unstructured":"SuzukiY TakasakaS KishimotoK et al.Combination treatment with an alpha1\u2010blocker plus an anticholinergic for the patients with suspected bladder outlet obstruction (boo) concomitant with over\u2010active bladder (OAB). Proceedings of the ICS 2004; 34th annual meeting in conjuction with the IUGA: Abstract 471."},{"key":"e_1_2_1_44_2","unstructured":"LimE ChiaSJ.Combination therapy using alpha\u2010blocker and antimuscarinic drugs in men with lower urinary tract symptoms suggestive of bladder outlet obstruction and an overactive bladder: Is it safe and efficacious?Proceedings of the ICS 2005; 35th annual meeting: Abstract 205."},{"key":"e_1_2_1_45_2","unstructured":"HerschornS AbramsP ChappleCR et al.\u201cAdd\u2010on\u201d tolterodine extended release improves overactive bladder symptoms in men receiving a\u2010blocker therapy. Program and abstracts of the AUA annual meeting 2008; May 17: Abstract 1291."},{"key":"e_1_2_1_46_2","unstructured":"KaplanSA ZoltanE TeAE.Safety and efficacy of tolterodine solifenacin and darifenacin in men with lower urinary tract symptoms (LUTS) on alpha\u2010blockers with persistent overactive bladder symptoms. Program and abstracts of the AUA Annual Meeting 2008; May 17\u201322: Abstract 2036."},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.05.050"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2006.06068.x"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2008.06.032"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.4065\/83.9.1002"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2006.06735.x"}],"container-title":["Neurourology and Urodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnau.20807","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnau.20807","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/nau.20807","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T03:00:10Z","timestamp":1700535610000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/nau.20807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":50,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.1002\/nau.20807"],"URL":"https:\/\/doi.org\/10.1002\/nau.20807","archive":["Portico"],"relation":{},"ISSN":["0733-2467","1520-6777"],"issn-type":[{"type":"print","value":"0733-2467"},{"type":"electronic","value":"1520-6777"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}